EvokAI Creative Labs Inc.

Equities

OKAI

CA30053J1012

Advanced Medical Equipment & Technology

Market Closed - Toronto S.E. Other stock markets 16:45:22 30/05/2024 BST			5-day change	1st Jan Change
0.085 ^CAD	-.--%		-34.62%	+13.33%

05-30	EvokAI Creative Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-29	EvokAI Creative Labs Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Sebastiani Ventures Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 05, 2022 at 09:09 pm

Sebastiani Ventures Corp. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was CAD 0.018603 million compared to CAD 0.018636 million a year ago.

Latest news about EvokAI Creative Labs Inc.

EvokAI Creative Labs Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-30	CI
EvokAI Creative Labs Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-29	CI
EvokAI Creative Labs Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-29	CI
EvokAI Creative Labs Inc. Receives Ce Mark Approval for Its Mdm Flex Sensor to Transform the Management of Parkinson's Disease	30/10/23	CI
EvokAI Creative Labs Inc. completed the acquisition of Rehaboo Oy.	22/06/23	CI
EvokAI Creative Labs Closes Acquisition of Extended Reality AI-Powered Company Neurocarrier Oy	16/06/23	MT
EvokAI Creative Labs Inc. completed the acquisition of NeuroCarrier Oy.	14/06/23	CI
EvokAI Creative Labs Inc. entered into a definitive agreement to acquire NeuroCarrier Oy.	31/05/23	CI
EvokAI Creative Labs Inc. completed the acquisition of Head Instruments Oy.	28/05/23	CI
EvokAI Creative Labs Inc. entered into a Share Purchase Agreement to acquire Rehaboo Oy for $4 million.	10/05/23	CI
EvokAI Creative Labs Inc. Auditor Raises 'Going Concern' Doubt	26/04/23	CI
EvokAI Creative Labs Inc. entered into a definitive agreement to acquire Head Instruments Oy for â‚¬4.4 million.	23/04/23	CI
EvokAI Creative Labs Inc. acquired Sebastiani Ventures Corp. (TSXV:SBS.H) in a reverse merger transaction	10/04/23	CI
Sebastiani Ventures Corp. Announces Board Appointments	21/12/22	CI
Sebastiani Ventures Corp. Appoints Alejandro Antalich as Chief Executive Officer	21/12/22	CI
EvokAI Creative Labs Inc. announced that it has received CAD 5 million in funding from Sebastiani Ventures Corp.	21/12/22	CI
Sebastiani Ventures Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	08/11/22	CI
EvokAI Creative Labs Inc. announced that it expects to receive CAD 5 million in funding from Sebastiani Ventures Corp.	16/08/22	CI
EvokAI Creative Labs Inc. entered into a binding letter of intent to acquire Sebastiani Ventures Corp. (TSXV:SBS.H) in a reverse merger transaction.	16/08/22	CI
Sebastiani Ventures Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	27/07/22	CI
Sebastiani Ventures Corp. announced that it has received CAD 0.25 million in funding	31/05/22	CI
EvokAI Creative Labs Inc. acquired 96% stake in Advancience Ltd from Baden Resources Limited for $2.05 million.	24/05/22	CI
Sebastiani Ventures Corp. announced that it expects to receive CAD 0.25 million in funding	18/05/22	CI
Sebastiani Ventures Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	05/05/22	CI
Sebastiani Ventures Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	09/04/22	CI

Chart EvokAI Creative Labs Inc.

Duration

Period

More charts

Company Profile

EvokAI Creative Labs Inc. is a MedTech artificial-intelligence-powered company. It is engaged in the development of transformational technologies for the modern health care sector. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. It offers its AI algorithms across the whole health care system, from hospitals, private clinics, research institutions, pharmaceutical companies, contract research organizations to medical professionals, patients, and healthy individuals, aiming at preventing and early detecting any kind of disease and protecting the aging genome. Its divisions include EvokAI Simulators, EvokAI Sensors, EvokAI Neurotrainer and EvokAI Medical. EvokAI Simulators combines cognitive neuroscience, virtual reality and artificial intelligence technologies to assess cognitive performance and spatial perception.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Medical Software & Technology Services

	1st Jan change	Capi.
EVOKAI CREATIVE LABS INC.	+13.33%	4.73M
VEEVA SYSTEMS INC.	-9.49%	31.38B
PRO MEDICUS LIMITED	+25.35%	8.33B
SECTRA AB	+33.25%	4.27B
EVOLENT HEALTH, INC.	-35.85%	2.47B
VERADIGM INC.	-9.44%	1.65B
OMNICELL, INC.	-13.39%	1.5B
LUNIT INC.	-32.84%	1.07B
SIMULATIONS PLUS, INC.	+7.80%	974M
B-SOFT CO.,LTD.	-37.56%	840M

Medical Software & Technology Services